| Dr Cynthia Joan Herrick, MD | |
|
4921 Parkview Pl, Div Im Endocrinology, Ste 5c, Saint Louis, MO 63110-1032 | |
| (314) 362-3500 | |
| (314) 230-1119 |
| Full Name | Dr Cynthia Joan Herrick |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 18 Years |
| Location | 4921 Parkview Pl, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316074743 | NPI | - | NPPES |
| 200014001 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 2012009714 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barnes Jewish Hospital | Saint louis, MO | Hospital |
| Christian Hospital Northeast | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington University | 9830008770 | 2506 |
News Archive
Receiving a cochlear implant early in life helps children with profound hearing loss to acquire language and communication skills similar to their hearing peers, according to an article in the May issue of the Archives of Otolaryngology—Head & Neck Surgery, a theme issue on pediatric cochlear implants and one of the JAMA/Archives journals.
Risk for cardiovascular disease, currently running rampant in the United States, can now be predicted for adolescents thanks to a new diagnostic test developed by a University of Virginia Children's Hospital pediatrician and his collaborators. The test accounts for many risk factors for the deadly disease and has the potential to be adapted by physicians nationwide to assess teenagers' future risk and encourage the healthy behaviors that could save their lives.
The brain plays an active and essential role much earlier than previously thought, according to new research from Tufts University scientists which shows that long before movement or other behaviors occur, the brain of an embryonic frog influences muscle and nerve development and protects the embryo from agents that cause developmental defects.
Eli Lilly and Company and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases. Alnara's lead product in development is liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT).
› Verified 8 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
Receiving a cochlear implant early in life helps children with profound hearing loss to acquire language and communication skills similar to their hearing peers, according to an article in the May issue of the Archives of Otolaryngology—Head & Neck Surgery, a theme issue on pediatric cochlear implants and one of the JAMA/Archives journals.
Risk for cardiovascular disease, currently running rampant in the United States, can now be predicted for adolescents thanks to a new diagnostic test developed by a University of Virginia Children's Hospital pediatrician and his collaborators. The test accounts for many risk factors for the deadly disease and has the potential to be adapted by physicians nationwide to assess teenagers' future risk and encourage the healthy behaviors that could save their lives.
The brain plays an active and essential role much earlier than previously thought, according to new research from Tufts University scientists which shows that long before movement or other behaviors occur, the brain of an embryonic frog influences muscle and nerve development and protects the embryo from agents that cause developmental defects.
Eli Lilly and Company and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases. Alnara's lead product in development is liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cynthia Joan Herrick, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 362-3500 | Dr Cynthia Joan Herrick, MD 4921 Parkview Pl, Div Im Endocrinology, Ste 5c, Saint Louis, MO 63110-1032 Ph: (314) 362-3500 |
News Archive
Receiving a cochlear implant early in life helps children with profound hearing loss to acquire language and communication skills similar to their hearing peers, according to an article in the May issue of the Archives of Otolaryngology—Head & Neck Surgery, a theme issue on pediatric cochlear implants and one of the JAMA/Archives journals.
Risk for cardiovascular disease, currently running rampant in the United States, can now be predicted for adolescents thanks to a new diagnostic test developed by a University of Virginia Children's Hospital pediatrician and his collaborators. The test accounts for many risk factors for the deadly disease and has the potential to be adapted by physicians nationwide to assess teenagers' future risk and encourage the healthy behaviors that could save their lives.
The brain plays an active and essential role much earlier than previously thought, according to new research from Tufts University scientists which shows that long before movement or other behaviors occur, the brain of an embryonic frog influences muscle and nerve development and protects the embryo from agents that cause developmental defects.
Eli Lilly and Company and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases. Alnara's lead product in development is liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT).
› Verified 8 days ago
Dr. Isik Turker, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 4921 Parkview Pl, Div Im Cardiology, Ste 8b, Saint Louis, MO 63110 Phone: 314-362-1291 Fax: 314-362-4278 | |
Conor Mccartney, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 915 N Grand Blvd, Saint Louis, MO 63106 Phone: 314-652-4100 | |
Dr. Faris Adam Bakeer, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Rehan Rais, M.D. M.B.,B.S. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 660 S Euclid Ave, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Nathan Farkas, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1 Barnes Jew Hosp Plz, Saint Louis, MO 63110 Phone: 314-362-1930 | |
Dr. Nicole Foley, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Soumojit Ghosh, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista Ave, Saint Louis, MO 63110 Phone: 314-977-6100 Fax: 314-977-6164 |